Literature DB >> 27355132

Remote ischemic postconditioning protects against renal ischemia/reperfusion injury by activation of T-LAK-cell-originated protein kinase (TOPK)/PTEN/Akt signaling pathway mediated anti-oxidation and anti-inflammation.

Sumin Gao1, Yi Zhu2, Haobo Li3, Zhengyuan Xia3, Qingping Wu2, Shanglong Yao2, Tingting Wang4, Shiying Yuan5.   

Abstract

BACKGROUND: Recent clinical and animal studies suggested that remote limb ischemic postconditioning (RIPostC) can invoke potent cardioprotection or neuroprotection. However, the effect and mechanism of RIPostC against renal ischemia/reperfusion injury (IRI) are poorly understood. T-LAK-cell-originated protein kinase (TOPK) is crucial for the proliferation and migration of tumor cells. However, the function of TOPK and the molecular mechanism underlying renal protection remain unknown. Therefore, this study aimed to evaluate the role of TOPK in renoprotection induced by RIPostC.
MATERIALS AND METHODS: The renal IRI model was induced by left renal pedicle clamping for 45min followed by 24h reperfusion and right nephrectomy. All mice were intraperitoneally injected with vehicle, TOPK inhibitor HI-TOPK-032 or Akt inhibitor LY294002. After 24h reperfusion, renal histology, function, and inflammatory cytokines and oxidative stress were assessed. The proteins were measured by Western blotting.
RESULTS: The results showed that RIPostC significantly protected the kidneys against IRI. The protective effects were accompanied by the attenuation of renal dysfunction, tubular damage, inflammation and oxidative stress. In addition, RIPostC increased the phosphorylation of TOPK, PTEN, Akt, GSK3β and the nuclear translocation of Nrf2 and decreased the nuclear translocation of NF-κB. However, all of the above renoprotective effects of RIPostC were eliminated either by the inhibition of TOPK or Akt with HI-TOPK-032 or LY294002.
CONCLUSIONS: The current data reveal that RIPostC protects against renal IRI via activation of TOPK/PTEN/Akt signaling pathway mediated anti-oxidation and anti-inflammation.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Akt; NF-κB; Nrf2; PTEN; Remote ischemic postconditioning; TOPK

Mesh:

Substances:

Year:  2016        PMID: 27355132     DOI: 10.1016/j.intimp.2016.06.020

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  16 in total

1.  Exosomes Derived from BMSCs Ameliorate Intestinal Ischemia-Reperfusion Injury by Regulating miR-144-3p-Mediated Oxidative Stress.

Authors:  Guangru Zhang; Zhanhai Wan; Zhenzhen Liu; Disheng Liu; Zhiyu Zhao; Yufang Leng
Journal:  Dig Dis Sci       Date:  2022-05-27       Impact factor: 3.487

2.  TOPK Activation Exerts Protective Effects on Cisplatin-induced Acute Kidney Injury.

Authors:  Hui Zhang; Qing-Qing Dong; Hua-Pan Shu; Yu-Chi Tu; Qian-Qian Liao; Li-Jun Yao
Journal:  Curr Med Sci       Date:  2022-06-09

3.  Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E2 Receptor EP4 Pathway.

Authors:  Yu Ah Hong; Keum Jin Yang; So Young Jung; Ki Cheol Park; Hyunsu Choi; Jeong Min Oh; Sang Ju Lee; Yoon Kyung Chang; Cheol Whee Park; Chul Woo Yang; Suk Young Kim; Hyeon Seok Hwang
Journal:  Oxid Med Cell Longev       Date:  2017-03-29       Impact factor: 6.543

4.  Very Delayed Remote Ischemic Post-conditioning Induces Sustained Neurological Recovery by Mechanisms Involving Enhanced Angioneurogenesis and Peripheral Immunosuppression Reversal.

Authors:  Thorsten R Doeppner; Bozena Zechmeister; Britta Kaltwasser; Fengyan Jin; Xuan Zheng; Arshad Majid; Vivek Venkataramani; Mathias Bähr; Dirk M Hermann
Journal:  Front Cell Neurosci       Date:  2018-10-29       Impact factor: 5.505

5.  Gene expression profiling analysis to investigate the role of remote ischemic postconditioning in ischemia-reperfusion injury in rats.

Authors:  Zanxin Wang; Junmin Wen; Chuzhi Zhou; Zhiwei Wang; Minxin Wei
Journal:  BMC Genomics       Date:  2019-05-09       Impact factor: 3.969

6.  Maresin 1 mitigates renal ischemia/reperfusion injury in mice via inhibition of the TLR4/MAPK/NF-κB pathways and activation of the Nrf2 pathway.

Authors:  Yun Qiu; Yichen Wu; Hongmei Zhao; Hong Sun; Sumin Gao
Journal:  Drug Des Devel Ther       Date:  2019-02-20       Impact factor: 4.162

7.  Anti-Inflammatory and Antioxidant Effect of Eucommia ulmoides Polysaccharide in Hepatic Ischemia-Reperfusion Injury by Regulating ROS and the TLR-4-NF-κB Pathway.

Authors:  Weidong Gao; Zanjie Feng; Shilong Zhang; Bo Wu; Xin Geng; Guoxin Fan; Yuling Duan; Kai Li; Kangwei Liu; Cijun Peng
Journal:  Biomed Res Int       Date:  2020-05-25       Impact factor: 3.411

Review 8.  PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential.

Authors:  Hai Huang; Mee-Hyun Lee; Kangdong Liu; Zigang Dong; Zeayoung Ryoo; Myoung Ok Kim
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639

9.  TOPK Promotes Microglia/Macrophage Polarization towards M2 Phenotype via Inhibition of HDAC1 and HDAC2 Activity after Transient Cerebral Ischemia.

Authors:  Ziping Han; Haiping Zhao; Zhen Tao; Rongliang Wang; Zhibin Fan; Yumin Luo; Yinghao Luo; Xunming Ji
Journal:  Aging Dis       Date:  2018-04-01       Impact factor: 6.745

10.  Targeting Oxidative Stress and Inflammation to Prevent Ischemia-Reperfusion Injury.

Authors:  Liquan Wu; Xiaoxing Xiong; Xiaomin Wu; Yingze Ye; Zhihong Jian; Zeng Zhi; Lijuan Gu
Journal:  Front Mol Neurosci       Date:  2020-03-05       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.